全球liquid biopsy marketsize is slated to reach USD 3,362.6 million by 2026 at a CAGR of 21.9% according to a news report published by Polaris Market Research. The report液体活检市场份额、规模、趋势和行业分析报告，[按技术（PCR微阵列，NGS）；按样本类型（血液、尿液、唾液、其他体液）；生物标志物（外显子体、CTC、ctDNA）；通过申请；2019-2026年细分市场预测provides a comprehensive analysis of present market insights and forecasted future trends.
液体活检是诊断癌症发病的常规方法。液体活组织检查的替代名称是液体活组织检查或液相活组织检查。这在很大程度上是一种非侵入性方法，用于跟踪一段时间内的肿瘤和突变。通过对肿瘤未来的观察，医生们了解到了这种疾病。虽然在癌症的早期检测中是简单和有用的，但它表达了对其采用的担忧。液体活检产品市场存在一个缺点，即组织活检在很大程度上掩盖了液体活检产品的市场地位，而组织活检产品被例外地采用。
Drivers to the market potential are the increasing number of patients being diagnosed with various types of cancer. The free trials accompanying surgery motivates growth. Minimal invasive surgery method unique to liquid biopsy market cap, invokes huge demand impacting market growth over forthcoming years.
A significant driver to growth of liquid biopsy is the reduced number of surgical invasions. This encouraging sign makes it one of the most adopted substitutes for tissue biopsy. An increasing trend followed by key players to shift focus onto research and development activities aiding strategic M&A improves market strength dramatically.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:
//m.jiayuancx.com/industry-analysis/liquid-biopsy-market
考虑到技术基础，单基因分析和多基因平行分析（NGS）主导了液体活检癌的市场规模。NGS表示一次诊断多种疾病。PCR是一种分析基因突变的方法。
2018年液体活检市场的另一类区别是基于样本类型。样本根据血液、唾液、尿液和其他体液进行分割。血液样本是进行常规分析的最佳样本类型，因为血液中含有游离DNA、循环细胞和外显体，使其易于检测，从而检测出人体内的癌细胞。
基于生物标志物类型、全球市场前景to 2026 is segmented into exosomes, circulating tumor cells (CTC) and circulating tumor DNA (ctDNA). CTC biomarkers govern largest market share owing to high awareness levels and accurate tracking results of cancerous cells in the body. CTC marker makes early forays in the initial stages of detection of cancer itself.
North America is holding coveted position as per geography in market cap during forecast period. Increased facilitators for diagnosis of cancer and rising number of patients suffering from cancer are factors promoting growth of market. Asia Pacific is exhibited to grow at a faster rate during forecast period.
The major players operating in market include Roche Diagnostics, Illumina Inc., Myriad Genetics, Inc., RainDance Technologies, Inc. among others.
betway苹果下载Polaris Market Research根据样本类型、应用、生物标记物类型和地区对全球液体活检市场进行了细分：
Liquid Biopsy Sample Type Outlook (Revenue USD Millions 2015-2026)
- Blood
- 尿
- Saliva
液体活检应用前景（2015-2026年收入百万美元）
- 分子健康监测
- Therapy Selection For Other Meta cancer
- MBS的治疗选择
液体活检生物标志物类型展望（2015-2026年收入百万美元）
- Exosomes
- Circulating tumor cells (CTC)
- Circulating tumor DNA (ct DNA)
液体活检区域展望（2015-2026年收入百万美元）
- North America
- America
- 加拿大
- 欧洲
- 德国
- UK
- 法国
- 意大利
- Asia Pacific
- 印度
- China
- Japan
- Latin America
- 墨西哥
- 巴西
- Middle East and Africa